MedPath

Role of Topical Vancomycin in Reducing Infections in Hip and Knee Arthroplasty

Not Applicable
Recruiting
Conditions
Osteoarthritis, Knee
Osteoarthritis, Hip
Avascular Necrosis of Hip
Rheumatoid Arthritis
Interventions
Procedure: 0,35% povidone-iodine solution lavage
Procedure: 1.0 g Vancomycin powder into the wound
Registration Number
NCT05972603
Lead Sponsor
Independent Public Healthcare Center in Rypin
Brief Summary

The study is designed to assess the efficacy of vancomycin powder and dilute povidone-iodine lavage (VIP protocol) in reducing the PJI after primary Total Hip Arthroplasty (THA) and Total Knee Arthroplasty (TKA). We hypothesized that VIP protocol provides superior reduction of periprosthetic joint infection (PJI) rates after primary THA and TKA compared with diluted povidone-iodine (PI) protocol.

Detailed Description

Patients who undergo primary hip or knee arthroplasty, before closure 0,35% povidone-iodine (17,5mL in 500 mL saline) solution lavage left for 3 minutes following final implantation.

Patients drawn by random numbers calculator will be administered with 1.0 g Vancomycin powder into the wound around the prosthesis and no suction will be used.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • undergoing THA or TKA as a result of osteoarthritis or rheumatoid arthritis, can understand and comply with the study protocol, have signed the informed consent document at screening
Exclusion Criteria
  • Patients referred to the hospital in order to undergo THA or TKA due to different reason than osteoarthritis, rheumatoid arthritis or avascular necrosis of the femoral head, such as: failed femoral neck fractures, displaced acetabular fractures or revision acetabular fractures, revision knee or hip arthroplasty

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
0,35% povidone-iodine solution lavage0,35% povidone-iodine solution lavage0,35% povidone-iodine solution lavage left in wound for 3 minutes following final implantation.
1.0 g Vancomycin powder into the wound1.0 g Vancomycin powder into the woundadditional 1.0 g Vancomycin powder into the wound
Primary Outcome Measures
NameTimeMethod
periprosthetic joint infection90 days

infection rate in each group

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

IPHC Rypin

🇵🇱

Rypin, Kujawsko-pomorksie, Poland

© Copyright 2025. All Rights Reserved by MedPath